Abstract:The Asian Alzheimer's disease (AD) instrument validation study is designed to assess if the major AD instruments developed in western countries are valid and reliable for use among the Asian AD population. The report here is the result of the first interim analysis. This is a multicenter, longitudinal, non-interventional study including five Asian countries/regions. The instruments included ADAS-Cog, DAD, Neuropsychological Test Battery (NTB), CDR, MMSE and Dependence Scale (DS). Study method was previously described in detail (poster 16402, AAICAD 2011). 302 participants (251AD patients, 51 healthy controls) were enrolled for the study. Screening and baseline data were analyzed here. The mean age of participants was 71 years (range: 50-85). Over half of participants were female (57%). Most participants were married (83%) and living with a spouse (71%). 32% of the subjects had at least some college education. The nationality of participants generally aligned with the region of their enrolment. Healthy controls showed better cognitive functioning than AD subjects (P<.05) with magnitude varying across the specific neuropsychological tests. Overall, minimal ceiling effect was found for AD subjects across various tests while ceiling effect was found for health y control for many tests. For AD participants, test-retest reliability was confirmed with ICC > 0.7 for 17 of 19 tests. Non-NTB tests were significantly (P< 0.05) correlated with each other and with NTB component, summary and total scores, supporting convergent and divergent validity. Greater disease severity corresponded to significantly (P< 0.003) poorer performance on nearly every assessment, supporting discriminant validity. ApoE4 was detected in 85 of 210 (40.5%) AD patients and 5 of 36 (13.9%) healthy controls (P=0.002). ApoE4 was detected in 44 (40.7%) with mild AD and 41 (40.2%) with moderate/severe AD. There were no significant differences among ApoE4 carriers and non-carriers on instrument scores. This study is the first to evaluate the psychometric properties of multiple AD instruments in five Asian countries/regions. These promising results support the initial psychometric properties of these instruments, enabling their use in Chinese, Korean, and English-speaking AD population in a psychometrically sound manner. Data collection is on-going to evaluate their responsiveness over time.

Early symptoms of Alzheimer's disease in Japan and Taiwan

Gender’s Effects to the Early Symptoms of Alzheimer’s Disease in 5 Asian Countries

Impact of Alzheimer's Disease in Nine Asian Countries

IC-P-045: Cognition Decline of Alzheimer's Disease Patients in a Memory Clinic Setting, Shanghai, China

A 12-Year Comparison of Patients with Alzheimer’s Dementia with Their Informants in Eight Asian Countries

Early Signs of Alzheimer's Disease in Community Population

A 12-year comparison of patients with Alzheimer's dementia with their informants in eight Asian countries

Delayed Help Seeking Behavior in Dementia Care: Preliminary Findings from the Clinical Pathway for Alzheimer's Disease in China (CPAD) Study.

Cognition Decline of Alzheimer Patients in a Memory Clinic Setting, Shanghai, China

Prevalence of Neuropsychiatric Symptoms Across the Declining Memory Continuum: an Observational Study in a Memory Clinic Setting

P3-459: Neuropsychiatric Features in Alzheimer's Disease and Mild Cognitive Impairment in Memory Clinic

Alzheimer’s Disease and Other Dementias in China: Secular Trend in Disease Burden from 1990 to 2019 and Projections to 2030

Demographic And Clinical Characteristics Related To Cognitive Decline In Alzheimer Disease In China: A Multicenter Survey From 2011 To 2014

Cognitive Decline in Patients with Alzheimer's Disease and Its Related Factors in a Memory Clinic Setting, Shanghai, China.

Survey on the current situation for early diagnosis of dementia and contributing factors in Japan

Alzheimer's Disease Instruments Validation Study in Asia

P17: What happens if your colleague was the first person who notice that you have early-onset dementia?

Characteristics of Alzheimer's Disease among Patients in Taiwan, Hong Kong, and Beijing.

Behavioural and Psychological Symptoms of Early‐onset and Late‐onset Alzheimer's Disease among Chinese Adults: Analysis of Modifiable Factors

Are the Revised Diagnostic Criteria for Alzheimer's Disease Useful in Low- and Middle-Income Countries?

Gender differences in presentation of behavioral and psychological symptoms in Alzheimer’s disease in Taiwan